Radar · Life Sciences in Florida
Best Life Sciences Companies in Florida, United States
The 776 best Life Sciences companies in Florida, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Celsius.
By Riya SenguptaFinancials
776companies tracked
$5Bdisclosed funding
0unicorns
259have raised
FLIAR INTELLIGENCE · LIFE SCIENCES × FLORIDA
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
164companies analysed
83%cloud-native stacks
2025funding peak (by rounds)
7unicorns
2016median founding year
415kcombined LinkedIn audience
76%of audience held by top 3
3companies hiring publicly (12 mo)
Ranked: Best Life Sciences companies in Florida
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Celsius Functional beverage company manufacturing energy drinks | $596M | 46 mo ago | Acquired | 1 | John Fieldly Chief Executive Officer | — | — |
| 2 | NeoGenomics Provider of cancer genetic diagnostic services | $446M | 64 mo ago | Public | 2,100 2,100 → 1,793 (-15%) | — | — | — |
| 3 | Beacon Therapeutics Developer of therapeutics for retinal disorders | $291M | 5 mo ago | Series C | 76 | Lance Baldo Chief Executive Officer | — | — |
| 4 | Neocis Provider of robotic guidance system for dental surgeries 74Innovation top 16%Patents top 17%Funding top 25%Moat top 26% All 10 signals ▾Innovationtop 16% Patentstop 17% Fundingtop 25% Moattop 26% Growthtop 33% Techtop 40% Markettop 48% Talentbottom 49% Globalbottom 42% Newsbottom 22% Innovation: 198 patents (top 8% of patent-holders) · 117 filings since 2022 vs 64 in 2017-21 Patents: 198 patents matched (strict assignee match) · 117 filings since 2022 vs 64 in 2017-21 rank vs industry peers · Fliar Intelligence Index 74/100 | $179M | 29 mo ago | Series D | 118 118 → 113 (-4%) | Alon Mozes Co-Founder & CEO | 198 patents Robotic-guided dental and cranio‑maxillofacial surgery systems and planning tools | 1 launch · 1 award |
| 5 | Momentis Surgical Developer of a minimally invasive robotic surgery device 50Moat top 22%Funding top 27%Talent top 38%Market top 49% All 6 signals ▾Moattop 22% Fundingtop 27% Talenttop 38% Markettop 49% Techbottom 45% Globalbottom 36% Moat: Editorial + unicorn rating 8/10 · Soonicorn Funding: Raised $112M across 5 rounds · 5 rounds over 10 yrs (0.5/yr) rank vs industry peers · Fliar Intelligence Index 50/100 | $112M | 31 mo ago | Series D | 135 | Nir Shvalb Founder | — | — |
| 6 | LensAR Laser Technology with AR feature for cataract surgery 67Innovation top 13%Patents top 14%Funding top 27%Fin. health top 27% All 10 signals ▾Innovationtop 13% Patentstop 14% Fundingtop 27% Fin. healthtop 27% Techtop 37% Moattop 44% Markettop 48% Newsbottom 44% Globalbottom 38% Growthbottom 29% Innovation: 377 patents (top 2% of patent-holders) · 175 filings since 2022 vs 101 in 2017-21 Patents: 377 patents matched (strict assignee match) · 175 filings since 2022 vs 101 in 2017-21 rank vs industry peers · Fliar Intelligence Index 67/100 | $99M | 36 mo ago | Acquired | 67 67 → 164 (+145%) | — | 377 patents Patents concentrated in health & consumer products | 1 partnership |
| 7 | LactaLogics Provider of human milk-based products for premature and at-risk infants | $92M | 27 mo ago | Funding Raised | 11 | Glenn Snow Co-Founder & CEO | 9 patents Enteral feeding devices and sterilized human milk production technologies | — |
| 8 | Oragenics Developer of novel treatments for infectious diseases and oral mucositis as well as probiotics for oral health | $87M | 34 mo ago | Public | 5 | Alan Joslyn CEO & President | 57 patents Intranasal delivery systems for TBI therapy, animal weight-control methods, and novel lantibiotic antibiotics | 2 launchs |
| 9 | Obvio Health Provider of clinical trials design and recruitment platform 48Funding top 27%Product top 34%Moat top 39%Tech top 44% All 11 signals ▾Fundingtop 27% Producttop 34% Moattop 39% Techtop 44% Growthtop 45% Partnerstop 45% Markettop 50% Talentbottom 49% Globalbottom 39% Newsbottom 18% Customersbottom 17% Funding: Raised $66.0M across 4 rounds · 4 rounds over 8 yrs (0.5/yr) Product: 18 published apps (10.9k installs) · Company stage: Series B rank vs industry peers · Fliar Intelligence Index 48/100 | $66M | 22 mo ago | Series B | 168 | Ivan Jarry Chief Executive Officer | — | 1 launch |
| 10 | Catalyst OrthoScience A total shoulder implant solution 60Funding top 20%Growth top 28%Patents top 28%Product top 31% All 11 signals ▾Fundingtop 20% Growthtop 28% Patentstop 28% Producttop 31% Techtop 32% Moattop 32% Innovationtop 36% Partnerstop 45% Globalbottom 36% Marketbottom 29% Newsbottom 18% Funding: Raised $50.1M across 8 rounds · 8 rounds over 11 yrs (0.7/yr) Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 60/100 | $50M | 7 mo ago | Series E | 17 | — | 71 patents Patents concentrated in health & consumer products | 1 job opening |
| 11 | Forward Therapeutics Developer of therapeutics for chronic inflammatory disorders | $50M | 31 mo ago | Series A | — | Toufike Kanouni Co-Founder and CEO | — | — |
| 12 | Belenos Biosciences Developer of bispecific antibody therapeutics for chronic inflammatory disease treatment | $48M | 23 mo ago | Series C | — | Glenn Rosen Co-Founder & Chief Translational Officer | — | — |
| 13 | TuHURA Biosciences Developer of immunotherapies for the treatment of cancer 42Funding top 20%Talent top 38%Moat top 39%Growth top 45% All 8 signals ▾Fundingtop 20% Talenttop 38% Moattop 39% Growthtop 45% Techbottom 47% Newsbottom 39% Globalbottom 36% Marketbottom 32% Funding: Raised $37.8M across 11 rounds · 11 rounds over 8 yrs (1.4/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 42/100 | $38M | 7 mo ago | Public | — | Patricia Lawman Co-Founder | — | — |
| 14 | DermaSensor Developer of an AI-powered skin cancer detection device 64Funding top 25%News top 29%Innovation top 35%Growth top 35% All 12 signals ▾Fundingtop 25% Newstop 29% Innovationtop 35% Growthtop 35% AItop 35% Producttop 35% Moattop 37% Techtop 38% Patentstop 42% Talentbottom 49% Marketbottom 34% Globalbottom 33% Funding: Raised $35.8M across 6 rounds · 6 rounds over 8 yrs (0.8/yr) News: 3 BI events in 12 mo (of 7 tracked, 3 types) · Top themes: Funding, Capital raise rank vs industry peers · Fliar Intelligence Index 64/100 | $36M | 8 mo ago | Series B | 24 | Cody Simmons CEO | 10 patents Non‑invasive optical spectroscopy for melanoma and skin cancer detection | — |
| 15 | Rational Vaccines Developer of live attenuated viral immunotherapeutic and prophylactic vaccine candidates 29Funding top 28%Moat top 38%Patents top 40%Innovation top 46% All 8 signals ▾Fundingtop 28% Moattop 38% Patentstop 40% Innovationtop 46% Talentbottom 49% Techbottom 42% Globalbottom 37% Marketbottom 25% Funding: Raised $30.6M across 12 rounds · 12 rounds over 11 yrs (1.1/yr) Moat: Editorial + unicorn rating 4/10 · IP moat: 9 patents rank vs industry peers · Fliar Intelligence Index 29/100 | $31M | 8 mo ago | Series B | 18 18 → 11 (-39%) | Agustin Fernandez Founder & CEO | 9 patents Serological SARS‑CoV‑2 diagnostics and recombinant vaccine platforms for intracellular pathogens. | — |
| 16 | Hesperos Developer of organ-on-a-chip solutions for preclinical testing | $29M | 13 mo ago | Funding Raised | 15 | James Hickman Co-Founder | 5 patents Microfluidic organ-on-chip platforms integrating immune function and cell‑printing for functional genomics | — |
| 17 | MyMD Pharmaceuticals Developer of small molecule therapeutics for various diseases | $27M | 24 mo ago | Public | 9 | — | — | 1 expansion |
| 18 | Enveric Developer of small-molecule therapeutics for the treatment of neuropsychiatric disorders 42Funding top 29%News top 30%Growth top 31%Talent bottom 49% All 9 signals ▾Fundingtop 29% Newstop 30% Growthtop 31% Talentbottom 49% Fin. healthbottom 42% Techbottom 38% Globalbottom 38% Marketbottom 36% Moatbottom 36% Funding: Raised $26.4M across 3 rounds · 3 rounds over 4 yrs (0.8/yr) News: 15 BI events in 12 mo (of 35 tracked, 3 types) · +200% YoY rank vs industry peers · Fliar Intelligence Index 42/100 | $26M | 2 mo ago | Public | 25 | Joseph Tucker CEO | — | — |
| 19 | TAS Medical Provider of solution to assist in laparoscopic hernia repair | $19M | 2 mo ago | Series A | 8 | Albert Chin Co-Founder | — | — |
| 20 | Emmune Biotechnology startup developing novel HIV treatment and prevention solutions | $18M | 13 mo ago | Funding Raised | 7 | Michael Alpert Co-Founder | 16 patents Patents concentrated in chemistry & materials | — |
| 21 | Syncromune Developer of therapeutic vaccines for the treatment of cancer | $14M | 18 mo ago | Series A | 13 | Eamonn Hobbs CEO | 5 patents Intratumoral cancer therapy combining tumor cell lysis agents with immunotherapeutic compounds | 1 job opening |
| 22 | AventuSoft Cloud connected wearable to detect heart related abnormalities 11Moat top 32%Funding top 39%Patents bottom 49%Talent bottom 45% All 8 signals ▾Moattop 32% Fundingtop 39% Patentsbottom 49% Talentbottom 45% Innovationbottom 38% Techbottom 35% Globalbottom 31% Marketbottom 10% Moat: Editorial + unicorn rating 4/10 · IP moat: 26 patents Funding: Raised $13.7M across 10 rounds · 10 rounds over 13 yrs (0.8/yr) rank vs industry peers · Fliar Intelligence Index 11/100 | $14M | 9 mo ago | Funding Raised | 4 | Kaustubh Kale Founder & CEO | 26 patents Non‑invasive cardiac monitoring and heart‑valve signal analysis using NFC biosensor patches | — |
| 23 | Omeza Discovering and developing solutions for closing chronic wounds and preventing their recurrence | $13M | 1 mo ago | Series A | 22 | — | 10 patents Topical marine oil formulations for wound healing and dermatological therapy | — |
| 24 | Black Light Surgical Developer of a device for imaging diagnostics of cancer | $13M | 11 mo ago | Series A | 1 | — | — | — |
| 25 | Accelus Provider of spine surgery robot systems for healthcare industries 45Talent top 28%Funding top 32%Moat top 39%Growth top 48% All 8 signals ▾Talenttop 28% Fundingtop 32% Moattop 39% Growthtop 48% Techbottom 43% Marketbottom 42% Globalbottom 37% Newsbottom 21% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Funding: Raised $12.0M across 4 rounds · 4 rounds over 4 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 45/100 | $12M | 13 mo ago | Series D | 101 | Alex Lukianov Co-Founder & Chairman | — | — |
| 26 | NAVIGANTIS Developer of a surgical device for treatment | $12M | 25 mo ago | Series A | — | Hyosig Kang Co-Founder | CTO at NAVIGANTIS Inc | — | — |
| 27 | Firebird Biomolecular Sciences Provider of modified DNA as reagents for research, synthetic biology, and diagnostics | $7M | 17 mo ago | Funding Raised | 9 | Steven Benner Founder | — | — |
| 28 | Aegle Therapeutics Developing extracellular vesicle therapies for debilitating rare diseases and dermatological disorders | $6M | 5 mo ago | Series A | 4 | — | — | — |
| 29 | Betaliq Developer of patented technology-based products for vision care | $6M | 12 mo ago | Series A | — | Barry Butler CEO | — | — |
| 30 | Modulation Therapeutics Developing innovative therapies targeting cancer and liver disease | $5M | 14 mo ago | Series A | — | Mark McLaughlin Co-Founder & EVP | — | — |
| 31 | AiM Medical Robotics Developer of intraoperative precision robotics for neurosurgery 27Growth top 35%Talent top 38%Funding top 43%News top 43% All 8 signals ▾Growthtop 35% Talenttop 38% Fundingtop 43% Newstop 43% Moattop 48% Globalbottom 36% Techbottom 30% Marketbottom 22% Growth: Fresh capital in last 24 mo Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 27/100 | $5M | 12 mo ago | Series A | 9 | Craig Pierson Founder | — | 1 partnership · 1 award |
| 32 | NutraLife BioSciences Manufacturer of nutraceuticals, wellness, and cannabis products | $4M | 10 mo ago | Public | 12 | Edgar Ward Founder & CEO | — | — |
| 33 | NeXtGen Biologics Regenerative medicine company pioneering axolotl-derived technology for advanced wound healing | $4M | 10 mo ago | Seed | 10 | — | — | 2 partnerships |
| 34 | Kiala Online retailer of nutritional supplements formulated for women's health needs | $3M | 4 mo ago | Funding Raised | — | Pete Christel Co-Founder & Co-Owner | — | — |
| 35 | Mel-Mont Medical Developer of molecular screening devices for the early detection of infectious diseases | $3M | 6 mo ago | Series A | 4 | Frank Melendez Co-Founder & CEO | — | 1 award |
| 36 | Myosin Therapeutics Developer of therapeutics for CNS-based disorders | $3M | 9 mo ago | Seed | 8 | Courtney Miller Co-Founder | — | — |
| 37 | NativeCardio Developer of a cardiovascular device for postoperative atrial fibrillation | $3M | 15 mo ago | Seed | — | Joseph Pergolizzi CEO | — | — |
| 38 | VuEssence Genome based diagnostic technology platform | $3M | 13 mo ago | Seed | 5 | Maha Sallam Founder & President | — | — |
| 39 | Everglades Biopharma Developing ligand-based therapies for neovascular diseases and cancer | $2M | 15 mo ago | Funding Raised | — | Nile Bank Co-Founder | — | — |
| 40 | NOK Therapeutics Developer of autologous natural killer (NK) cell therapies for cancer | $2M | 20 mo ago | Seed | — | Robert Lewis Co-Founder & CEO | — | — |
| 41 | Deluge Biotechnologies Developer of peptide-inspired constrained oligomers for the synthesis and screening of DNA-encoded | $2M | 15 mo ago | Funding Raised | 15 | Thomas Kodadek Co-Founder | — | — |
| 42 | Captiva Spine Developing devices for spinal disorders | $2M | 14 mo ago | Seed | 20 20 → 26 (+30%) | Dale Mitchell CEO & Founder | — | 1 launch |
| 43 | LaserSight Technologies Laser technologies for refractive vision correction | $1M | 3 mo ago | Seed | 20 | — | — | — |
| 44 | HyperFlex Developer of minimally invasive bunion correction system for mild-to-moderate hallux valgus | $1M | 12 mo ago | Seed | — | Bob Peterhans Chief Executive Officer | — | — |
| 45 | Adolore Biotherapeutics Developer of non-opioid analgesics for the treatment of pain | $1M | 9 mo ago | Seed | — | Joseph Glorioso Founder | — | — |
| 46 | Platform Innovations Provider of AI-based laparoscopic device for minimally invasive surgery | $1M | 9 mo ago | Seed | 1 | Steve Jones CEO | — | — |
| 47 | Longeveron Developer of cellular therapies for aging-related and life-threatening conditions | $1M | 3 mo ago | Public | 23 23 → 41 (+78%) | Joshua Hare Co-Founder | 38 patents Mesenchymal stem cell therapeutics and potency assays for neurodegenerative and sexual health | 1 job opening |
| 48 | CirculaTech Developer of a flagship product in development | $1M | 15 mo ago | Funding Raised | — | Jake Pistiner Founder & CEO | — | — |
| 49 | NOVODX Developer of point-of-care diagnostic test for in-home and clinical applications | $1M | 15 mo ago | Seed | — | Nancy Kaufman CEO | — | — |
| 50 | Soilcea Developing HLB-resistant citrus trees using CRISPR technology for Florida's citrus industry | $750K | 15 mo ago | Seed | 3 | Chana Cannon Co-Founder & VP | — | — |
Top 12 Life Sciences companies in Florida
#1
Series C · Alachua, Florida · founded 2023 · 76 employees$290.7Mraised▾
Series C · Alachua, Florida · founded 2023 · 76 employees
Developer of therapeutics for retinal disorders. It offers gene therapies which include AGTC-501, to treat X-linked retinitis pigmentosa (XLRP), and other pipeline candidates for dry age-related macular degeneration and cone-rod dystrophy.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 10k LinkedIn followers — 2.4% of this cohort's audience
Funding rounds
- Jan 2026Series C$75M
- Jul 2024Series B$170M
- Jun 2023Series A$120.7M
Founders & team
Investors
Oxford Science Enterprises, University of Oxford, Syncona, Forbion, TCG Crossover, Advent Life Sciences
Tech stack
AosCloudflareCloudflare Browser InsightsComplianzHstsHttp/3
#2
Public · Naples, Florida · founded 1994 · 25 employees$26.4Mraised▾
Public · Naples, Florida · founded 1994 · 25 employees
Developer of small-molecule therapeutics for the treatment of neuropsychiatric disorders. The company leverages discovery and development platform Psybrary developing combination therapies with chemotherapeutic agents and immunotherapies for anxiety, depression, and addiction disorders.
Fliar Intelligence Index™ 42how this company ranks against its industry peers
Funding
top 29%News
top 30%Growth
top 31%Talent
bottom 49%Fin. health
bottom 42%Tech
bottom 38%Funding: Raised $26.4M across 3 rounds · 3 rounds over 4 yrs (0.8/yr) · Last round Post IPO (Apr 2026)
News: 15 BI events in 12 mo (of 35 tracked, 3 types) · +200% YoY · 7 high-value events (IPO/M&A/funding/contracts) in 12 mo
Growth: Headcount 23 → 25 (+9%) across vintages · Fresh capital in last 24 mo
Audience (LinkedIn): 4k LinkedIn followers
Funding rounds
- Apr 2026Post IPO$5M
- Apr 2023Post IPO$12.8M
- Aug 2022Post IPO$8.6M
Founders & team
Tech stack
Anime.JsCloudflareCloudflare Bot ManagementCore-JsFont AwesomeGodaddy
#3
Series A · Windermere, Florida · founded 2017 · 8 employees$18.6Mraised▾
Series A · Windermere, Florida · founded 2017 · 8 employees
Provider of solution to assist in laparoscopic hernia repair. Its product Trans Abdominal Strap assists in reducing the need for invasive surgical procedures and use of mesh for hernia treatment. It has surgical-grade zip straps are allowing surgeons to convert complex abdominal hernias from open surgery to robotic surgery.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 335 LinkedIn followers
Funding rounds
- Mar 2026Series A$3.9M
- Aug 2024Series A$4.2M
- Nov 2022Series A$3.2M
- Nov 2020Series A$5.2M
Founders & team
#4
Series A · Sarasota, Florida · founded 2005 · 22 employees$13Mraised▾
Series A · Sarasota, Florida · founded 2005 · 22 employees
Discovering and developing solutions for closing chronic wounds and preventing their recurrence. Its product includes omeza omega-3 oil that helps moisturize and exfoliate the skin while improving skin elasticity and supporting healing, omeza lidocaine lavage for pain relief, and omeza collagen matrix among others.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers
Funding rounds
- Apr 2026Series A$8.5M
- Dec 2024Series A$906.3K
- Mar 2021Series A$5M
- Aug 2019Series A$7M
Investors
Astanor, Catalyst, Florida Opportunity Fund, BluKap
Tech stack
Apple Icloud MailGeneratepressGeneratepress Gp PremiumGodaddyGoogle AdsGoogle Ads Conversion Tracking
#5
Series E · Naples, Florida · founded 2011 · 17 employees$50.1Mraised▾
Series E · Naples, Florida · founded 2011 · 17 employees
Catalyst OrthoScience has developed, Catalyst CSR Shoulder System, a total shoulder implant solution. It is a bone-preserving, less invasive solution indicated for Osteoarthritis, Avascular Necrosis, Rheumatoid Arthritis, Post-traumatic Arthritis, and Correction of functional deformity. The company has received FDA clearance for it shoulder system.
Fliar Intelligence Index™ 60how this company ranks against its industry peers
Funding
top 20%Growth
top 28%Patents
top 28%Product
top 31%Tech
top 32%Moat
top 32%Funding: Raised $50.1M across 8 rounds · 8 rounds over 11 yrs (0.7/yr) · Last round Series E (Oct 2025)
Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo
Patents: 71 patents matched (strict assignee match) · 36 filings since 2022 vs 34 in 2017-21 · Latest publication 2026
Audience (LinkedIn): 5k LinkedIn followers
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Regional Sales Director (RSD)
Funding rounds
- Oct 2025Series E$15M
- Oct 2025Conventional Debt—
- Jul 2025Series E$4.1M
- Sep 2024Series E$20M
Investors
RC Capital, Mutual Capital Partners, Bridge Bank, Western Alliance Bank, Tamiami Angel Funds
Tech stack
All In One SeoAnimate.CssAnime.JsCloudflareCloudflare Bot ManagementContact Form 7
#6
Public · Tampa, Florida · founded 1996$37.8Mraised▾
Public · Tampa, Florida · founded 1996
Developer of immunotherapies for the treatment of cancer. The company is focused on developing novel personalized cancer vaccines and inhibitors of myeloid-derived suppressor cells(MDSCs). The company's lead candidate is IFx-2.0 personalized cancer vaccine involves a simple injection into a patient’s tumor of a small amount of pDNA that encodes for an immunogenic bacterial protein which gets expressed on the surface of the patient’s tumor.
Fliar Intelligence Index™ 42how this company ranks against its industry peers
Funding
top 20%Talent
top 38%Moat
top 39%Growth
top 45%Tech
bottom 47%News
bottom 39%Funding: Raised $37.8M across 11 rounds · 11 rounds over 8 yrs (1.4/yr) · Last round Unattributed (Oct 2025)
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Moat: Editorial + unicorn rating 7/10 · 10 curated direct competitors tracked
Funding rounds
- Oct 2025Unattributed$1.5M
- Jun 2025Unattributed$2.2M
- Dec 2023Unattributed$1.7M
- Jul 2022Unattributed$9.1M
Founders & team
Investors
Valirx, HHS
Tech stack
Amazon CloudfrontAmazon Web ServicesApache Http ServerBootstrapCookieyesDivi
#7
Series B · Miami, Florida · founded 2009 · 24 employees$35.8Mraised▾
Series B · Miami, Florida · founded 2009 · 24 employees
Developer of an AI-powered skin cancer detection device. The company offers DermaSensor device that uses a combination of cutting-edge optical spectroscopy and artificial intelligence to promptly analyze suspicious skin lesions. The device shines light bursts on a lesion, captures scattered light spectra, and uses proprietary AI algorithms to assess malignancy risk for melanoma, basal cell carcinoma, and squamous cell carcinoma.
Fliar Intelligence Index™ 64how this company ranks against its industry peers
Funding
top 25%News
top 29%Innovation
top 35%Growth
top 35%AI
top 35%Product
top 35%Funding: Raised $35.8M across 6 rounds · 6 rounds over 8 yrs (0.8/yr) · Last round Series B (Oct 2025)
News: 3 BI events in 12 mo (of 7 tracked, 3 types) · Top themes: Funding, Capital raise
Innovation: 10 patents (top 62% of patent-holders) · 7 filings since 2022 vs 2 in 2017-21 · 3 product lines
Audience (LinkedIn): 6k LinkedIn followers
Funding rounds
- Oct 2025Series B$16M
- Nov 2024Series B$8.9M
- Jun 2022Series B$10M
- Dec 2021Series A$8.5M
Founders & team
Investors
Ceros Capital Markets, SternAegis Ventures, Miami Angels, Pier 70 Ventures, Kern Venture Group, GenHenn Capital
Tech stack
Amazon Web ServicesAnime.JsApache Http ServerApple Icloud MailAstraAws Certificate Manager
#8
Series B · Miami, Florida · founded 2015 · 18 employees$30.6Mraised▾
Series B · Miami, Florida · founded 2015 · 18 employees
Developer of live attenuated viral immunotherapeutic and prophylactic vaccine candidates. The company focuses on combating diseases resulting from herpes simplex virus infections. It aims to reduce suffering of those infected and reduce the spread of the virus. The goal is to revolutionize the treatment, prevention, and diagnosis of herpes and related diseases.
Fliar Intelligence Index™ 29how this company ranks against its industry peers
Funding
top 28%Moat
top 38%Patents
top 40%Innovation
top 46%Talent
bottom 49%Tech
bottom 42%Funding: Raised $30.6M across 12 rounds · 12 rounds over 11 yrs (1.1/yr) · Last round Grant (prize money) (Sep 2025)
Moat: Editorial + unicorn rating 4/10 · IP moat: 9 patents
Patents: 9 patents matched (strict assignee match) · 9 filings since 2022 vs 0 in 2017-21 · Latest publication 2025
Audience (LinkedIn): 816 LinkedIn followers
Funding rounds
- Sep 2025Grant (prize money)$266.6K
- Apr 2025Grant (prize money)$291.5K
- Jan 2025Grant (prize money)$1.3M
- Aug 2023Grant (prize money)$1.3M
Founders & team
Investors
HHS, Abstract Ventures, Globivest
#9
Funding Raised · Boca Raton, Florida · founded 2013 · 4 employees$13.7Mraised▾
Funding Raised · Boca Raton, Florida · founded 2013 · 4 employees
AventuSoft is developing a cloud-connected wearable device that can be used to monitor heart rate for detecting heart-related abnormalities. The company has filed a patent for a device that can monitor the functioning of the human heart by monitoring and tracking heart beats. The company has also developed a cloud-based solution for speech analysis to detect and analyse speech disorders.
Fliar Intelligence Index™ 11how this company ranks against its industry peers
Moat
top 32%Funding
top 39%Patents
bottom 49%Talent
bottom 45%Innovation
bottom 38%Tech
bottom 35%Moat: Editorial + unicorn rating 4/10 · IP moat: 26 patents
Funding: Raised $13.7M across 10 rounds · 10 rounds over 13 yrs (0.8/yr) · Last round Grant (prize money) (Sep 2025)
Patents: 26 patents matched (strict assignee match) · 5 filings since 2022 vs 17 in 2017-21 · Latest publication 2024
Funding rounds
- Sep 2025Grant (prize money)$349.9K
- Apr 2025Grant (prize money)$2.1M
- Apr 2023Grant (prize money)$1.3M
- Apr 2020Grant (prize money)$3.7M
Founders & team
Investors
HHS, America’s Seed Fund
Tech stack
WordpressMysqlPhpAstraZurb FoundationAnimate.Css
#10
Series A · Miami, Florida · founded 2013 · 4 employees$6.5Mraised▾
Series A · Miami, Florida · founded 2013 · 4 employees
Developing extracellular vesicle therapies for debilitating rare diseases and dermatological disorders. The company pioneers regenerative medicine, utilizing extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs) to treat conditions with significant unmet medical needs. Their platform technology focuses on harnessing the regenerative, immunomodulatory, and anti-inflammatory potential of MSC-derived EVs. The company's approach involves cell-free therapies that deliver a natural biomolecular payload to treat disorders. Their patented EV harvesting technology allows for gentle isolation of EVs from MSCs. The lead product candidate targets dystrophic epidermolysis bullosa (DEB), addressing the protein collagen deficiency associated with the disease. The company's therapies aim to induce protein production, deliver essential cargo for tissue regeneration, reduce inflammation, accelerate healing, and improve overall cosmesis. This innovative approach has broad therapeutic potential in dermatology, immunology-based diseases, and protein deficient disorders.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 1k LinkedIn followers
Funding rounds
- Dec 2025Conventional Debt$455.7K
- Jul 2020Series A$6.5M
Investors
New World Angels, DeepWork Capital, Ocean Azul Partners, DEFTA Partners, Tellus BioVentures, Springboard Enterprises
Tech stack
BluehostBootstrapCalendlyCore-JsGoogle AnalyticsHsts
#11
Funding Raised · Orlando, Florida · founded 2015 · 15 employees$29.1Mraised▾
Funding Raised · Orlando, Florida · founded 2015 · 15 employees
Developer of organ-on-a-chip solutions for preclinical testing. The company has a heart-liver two organ model, heart-liver- skeletal muscle-neuron organ model, neuromuscular junction organ model, and heart-liver-cancer two organ model. These are a pumpless body-on-a-chip platform that uses a serum-free cellular medium, integrated computer modeling software, and physiological monitoring solutions.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 4k LinkedIn followers
Funding rounds
- Apr 2025Grant (prize money)$2M
- Aug 2021Grant (prize money)$2M
- Sep 2020Grant (prize money)$1.8M
- Sep 2018Grant (prize money)$1.7M
Founders & team
Investors
NCATS, HHS
Tech stack
WordpressMysqlPhpGeneratepressZurb FoundationAnimate.Css
#12
Funding Raised · Miami, Florida · founded 2023$3Mraised▾
Funding Raised · Miami, Florida · founded 2023
Online retailer of nutritional supplements formulated for women's health needs. The company offers powder and gummy supplements designed to support gut health, digestion, energy, and skin. Products contain superfoods, prebiotics, probiotics, and adaptogens.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 257 LinkedIn followers
Activity: 2 product launches announced in 12 mo
Funding rounds
- Feb 2026Conventional Debt$3M
Founders & team
Investors
Jpalmercollective
Tech stack
Amazon SesAmazon Web ServicesApple PayCart FunctionalityCloudflareCloudflare Bot Management
Funding & investor landscape
$5Btotal disclosed funding
268companies funded
819disclosed rounds
3rounds last 90 days
Most active investors
Notable founders
Lance Baldo
Chief Executive Officer · Beacon Therapeutics
Joseph Tucker
CEO · Enveric
Albert Chin
Co-Founder · TAS Medical
Thomas Kramer
Co-Founder & COO · TAS Medical
Patricia Lawman
Co-Founder · TuHURA Biosciences
James Bianco
CEO · TuHURA Biosciences
Cody Simmons
CEO · DermaSensor
Agustin Fernandez
Founder & CEO · Rational Vaccines
Kaustubh Kale
Founder & CEO · AventuSoft
James Hickman
Co-Founder · Hesperos
Pete Christel
Co-Founder & Co-Owner · Kiala
Jack Szymczak
Co-Founder & Co-Owner · Kiala
Prism market signals · United States · country-scoped Prism corpus, 1,465,538 docs
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH IN FLORIDA · Health & Bio
How research on Biotechnology in Florida is moving
A read on the academic research around Biotechnology in Florida — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 155 papers.
Florida's University of Florida, Mayo Clinic, and USF lead moderately optimistic biotechnology research, predominantly advancing RNA interference, gene delivery, and ALS therapeutics with growing recent momentum.
155 papers · stance +0.34 · 28% breakthrough · 27% concern
top institutions
- University of Florida83
- Mayo Clinic in Florida21
- University of South Florida13
- Florida College11
- Florida Agricultural and Mechanical University7
leading researchers
Ali Sarkhosh · Fariborz Habibi · Jeffrey K. Brecht · Naeem Khan · Tania F. Gendron · Xingbo Wu
prism intelligence · tone & topics
89% positive · 3% critical tone
HealthAgriculturePharmaceuticalsBiologyMedical ResearchGenetics
▲
Breakthroughs34 · 22%
▼ 35%→18% share
▼0.5× share momentum0 median citations65% since 2021mostly empirical
Aptamer research is rising with 4 papers, but Breakthroughs field-share dropped sharply from 35% to 18%.
rising sub-themes (early→recent)
- Aptamer4
- In vivo3
- Polymerase chain reaction3
- Population2
- Xylose2
Newly emergingPolymerase chain reaction 0→3
Landmark A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells · 2,506 cites
◆
Advancements54 · 35%
▲ 32%→36% share
▲1.1× share momentum0 median citations80% since 2021mostly empirical
Agriculture and Gene expression research intensifying — both newly emerging with 4 papers as Advancements share grows 32% to 36%.
rising sub-themes (early→recent)
- Agriculture4
- Gene expression4
- Gene3
- Gene knockdown3
- Aptamer3
Newly emergingAgriculture 0→4 · Gene expression 0→4 · Gene 0→3
Landmark Chemical and Physicochemical Pretreatment of Lignocellulosic Biomass: A Review · 1,003 cites
▼
Concerns32 · 21%
▲ 16%→21% share
▲1.3× share momentum0 median citations81% since 2021mostly reviews
Food safety and Food processing concerns newly emerging with 3 papers each as Concerns field-share rises 16% to 21%.
rising sub-themes (early→recent)
- Population3
- Food safety3
- Food processing3
- Biofilm2
- Food industry2
Newly emergingFood safety 0→3 · Food processing 0→3
Landmark Genomic responses in mouse models poorly mimic human inflammatory diseases · 2,962 cites
Common questions
How many Life Sciences companies are there in Florida, United States?
Radar tracks 776 indexable Life Sciences companies headquartered in Florida, United States that meet our profile-completeness bar.
What is the total funding raised by Life Sciences companies in Florida, United States?
The Life Sciences companies in Florida, United States on this list have raised a combined $5B in disclosed equity funding across 268 funded companies.
Which is the highest-funded Life Sciences company in Florida, United States?
Celsius is the highest-funded Life Sciences company in Florida, United States, with $595.7M in disclosed equity funding.
How many Life Sciences companies in Florida, United States are funded?
268 of the 776 Life Sciences companies in Florida, United States on this list have disclosed at least one equity funding round.
How many Life Sciences unicorns are there in Florida, United States?
None of the Life Sciences companies in Florida, United States on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Florida, United States Life Sciences companies?
The most active investors in Florida, United States Life Sciences companies on this list include HHS, National Science Foundation, NIH, New World Angels, Florida Institute.
Riya SenguptaFinancials
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.